TY  - JOUR
A1  - Jurayev J.S.,, Jurayev J.S.,
A1  - Karshiev.M.A, Karshiev.M.A
A1  - Uralov A.A, Uralov A.A
SP  - 98
VL  - 1
Y1  - 2024/05/12/
AV  - public
IS  - 4
N2  - Viral hepatitis C is one of the leading liver diseases. According to WHO, 70 million people are infected with this disease. HCV kills 290,000 people every year. In 95% of patients, the disease becomes chronic, and the main complications are fibrosis and cirrhosis of the liver. In some cases, a relapse is observed, despite treatment with antiviral drugs.
TI  - RECURRENCE OF CHCV AFTER THE USE OF DIRECT ANTIVIRAL  DRUGS: CLINICS, DIAGNOSIS, TREATMENT AND OUTCOMES
KW  - extrahepatic manifestations
KW  -  relapse
KW  -  IFN + riboverine
KW  -  retreatment of  relapse HCV RNA genotype 1b.
JF  - INTERNATIONAL CONFERENCE ON MEDICINE, SCIENCE, AND EDUCATION
EP  - 99
ID  - arxiv97684
UR  - https://universalconference.us/index.php/icmse/article/view/1301
ER  -